B. Boroojerdi et al., INTERHEMISPHERIC INHIBITION IN PATIENTS WITH MULTIPLE-SCLEROSIS, ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 109(3), 1998, pp. 230-237
Objectives: A single focal magnetic stimulus applied to the motor cort
ex of normal subjects can suppress ongoing voluntary electromyographic
activity in ipsilateral small hand muscles. This inhibition is mediat
ed from one motor cortex to the contralateral side via a transcallosal
pathway. Methods: We have investigated transcallosal inhibition in 24
patients with definite multiple sclerosis (MS) and in 24 healthy volu
nteers. A focal magnetic stimulus was applied to the hand area of the
motor cortex and the onset latency of the inhibition of the ongoing EM
G activity of the ipsilateral first dorsal interosseus muscle was eval
uated. Cortico-motor conduction time to the same muscle was revealed,
using a magnetic stimulus over the contralateral motor cortex. The dif
ference between these values was calculated as transcallosal conductio
n time. Cerebral magnetic resonance imaging (MRI) scans including sagi
ttal T-2-weighted images were performed in 18 patients. Results: The d
epth of inhibition (maximal inhibition as percentage of the baseline E
MG) in the MS patients was comparable to normal values, but the transc
allosal conduction time was significantly delayed (patients 17.2 +/- 6
.4 ms; normal subjects 12.2 +/- 2.6 ms; P < 0.001). The duration of th
e inhibition was significantly prolonged in MS patients (patients 47.9
+/- 20.9 ms; normal subjects 38.9 +/- 10.1 ms; P = 0.02). Transcallos
al conduction time was delayed in 11 (46%) of 24 patients, compared wi
th normal subjects. It exceeded the normal range (mean +/- 2.5 SD) in
one normal subject (specifity 96%). No correlation could be found betw
een the size or extent of the lesions obtained from the MRI scan and t
he onset latency or the depth of the inhibition. Conclusions: We concl
ude that conduction over transcallosal connections is significantly sl
ower in patients with MS. (C) 1998 Elsevier Science Ireland Ltd. All r
ights reserved.